Compare FFWM & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFWM | QSI |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | 485 | 145 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.3M | 165.3M |
| IPO Year | 2014 | N/A |
| Metric | FFWM | QSI |
|---|---|---|
| Price | $5.90 | $0.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $6.17 | $1.00 |
| AVG Volume (30 Days) | 845.0K | ★ 3.1M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,373,000.00 | N/A |
| Revenue This Year | $56.34 | N/A |
| Revenue Next Year | $10.68 | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.42 | $0.72 |
| 52 Week High | $6.72 | $3.10 |
| Indicator | FFWM | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 34.20 |
| Support Level | $5.44 | N/A |
| Resistance Level | $5.97 | $1.11 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 80.63 | 12.24 |
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.